2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Pancreatic Cancer Highlights: Is Perioperative mFOLFIRINOX More Beneficial Than Gem/nab-P in Resectable Disease? Should Neoadjuvant Therapy Be Considered for Borderline Resectable Disease?

828 views
July 14, 2020
Comments 0
Login to view comments. Click here to Login